Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
220 CHF | +0.02% | -2.22% | -10.02% |
09:58am | Roche: approval in lung cancer in the United States | CF |
08:48am | Nykode Therapeutics Launches Phase 2 Clinical Trial for Cervical Cancer Vaccine | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.02% | 194B | |
+27.97% | 672B | |
+23.68% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.36% | 211B | |
-0.37% | 203B | |
-11.81% | 144B | |
-8.80% | 141B |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- Roche Wins Conditional Approval For First-in-class Blood Cancer Therapy In EU